Jim Simons Ampio Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.16 - $0.47 $293,099 - $860,978	-1,831,869 Reduced 80.78%	435,900 $73,000
Q1 2022 May 13, 2022	SELL	$0.42 - $0.62 $56,503 - $83,409	-134,531 Reduced 5.6%	2,267,769 $1.07 Million
Q4 2021 Feb 11, 2022	BUY	$0.56 - $1.71 $1.35 Million - $4.11 Million	2,402,300 New	2,402,300 $1.37 Million
Q1 2020 May 14, 2020	SELL	$0.36 - $0.74 $51,404 - $105,663	-142,789 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$0.35 - $0.58 $11,378 - $18,856	-32,511 Reduced 18.55%	142,789 $83,000
Q3 2019 Nov 13, 2019	BUY	$0.38 - $0.52 $66,614 - $91,156	175,300 New	175,300 $88,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.